Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1991-11-13
2000-07-18
Johnson, Nancy A.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303871, 5303882, 53038824, 53038885, 435 7021, C07K 1618, C07K 1624
Patent
active
060909234
ABSTRACT:
A cytotoxic protein expressed by human peripheral blood mononuclear cells is isolated in essentially homogenous form. This protein may be used to elicit production of polyclonal or monoclonal anti-cytotoxin antibodies.
Hybridomas secreting anti-cytotoxin antibodies are identified by a solid phase bioassay. The antibodies are useful in the immunopurification of cytotoxins. The purified cytotoxic proteins are useful for the treatment of virus-infected or tumor target cells, either alone or in combination with interferon or a metabolic blocker.
REFERENCES:
patent: 4684623 (1987-08-01), Larrick et al.
patent: 4879226 (1989-11-01), Wallace
patent: 4880915 (1989-11-01), Kajihara et al.
patent: 5654407 (1997-08-01), Boyle et al.
patent: 5672347 (1997-09-01), Aggarwal et al.
patent: 5698419 (1997-12-01), Wolpe et al.
patent: 5795967 (1998-08-01), Aggarwal et al.
Adevka et al Antiviral Res. 5/Suppl 1:141-48, 1985.
Matthews et al Immunol. 48:321-27, 1983.
De St Goth et al J. Immunol. Meth. 35:1-21, 1980.
De St Groth, J. of Imm. Metho 35:1-21 (1980) "Production of Monoclonal Antibodies".
Wallach et al, "Regulatory Determinants in the Function and Formation of Human Lymphotoxins Applied For Developing Monoclonal Antibodies Against These Proteins." 4.sup.th International Lymphokine Workshop on Molecular and Cellular Biology of Lymphokines, Oct. 17-24, 1984. Lymphokine Res. 3(4) 1984.
Hahn et al, Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein PNAS, V. 82 pp. 3814-3818, Jun. 1985.
Matthews, Effect on human monocyte killing of tumour cells of antibody raised against an extracellular monocyte cytotoxin, Immunology v. 48, pp. 321-327, 1983.
Kohler and Milstein, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature V.256, 1975.
Bringman et al, "Antigenic Distinction between Human Lymphotoxin and Tumor Necrosis Factor Defined with Monoclonal Antibodies," Hybridoma, V4, 85, 1985.
Hass et al, "Characterization of Specific High Affinity Receptors for Human Tumor Necrosis Factor on Mouse Fibroblasts," J.Biol.Chem., V. 260, 12214-18, 1985.
Aderka, et al.; Tumor Necrosis Factor Induction By Sendai Virus; J. Immunol.; 136(8):2938-42 (1986).
Pennica, et al.; Human Tumor Necrosis Factor:Precursor Structure, Expression. and Homology to Lymphotoxin; Nature; 312:724-8 (1984).
Aggarwalt, et al.; Human Tumor Necrosis Factor; J. Biol. Chem.; 260:2345-54 (1985).
Old, L.J.; Tumor Necrosis Factor (TNF); Science; 230:630-32 (1985).
Eshhar Zelig
Hahn Talia
Wallach David
Johnson Nancy A.
Yeda Research and Development Co. Ltd.
LandOfFree
Murine monoclonal antibody binding TNF.alpha. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Murine monoclonal antibody binding TNF.alpha., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Murine monoclonal antibody binding TNF.alpha. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2038105